Table 5.

Treatment characteristics among the included studies

Study	Amino-salicylates, %	Corticosteroids, %	Immunomodulators, %	Anti-TNFα, %	Hospitalization, %	Surgery, %
Al-Shamali et al. [13]	93	60.0	68.0	−	−	−
Alharbi et al. [18]	100	73.6	37.9	4.9	44.5	3.8
Siddique et al. [11]	100	59.0	11.1	−	71.0	−
Al Fadda et al. [2, 20]	62	62.5	17.5	8.3	−	5.8
Abdulla et al. [21]	86	69.0	33.0	4.0	47.0	20.0

TNFα, tumor necrosis factor alpha.